Verus Financial Partners Inc. Has $264,000 Stock Holdings in Maximus, Inc. (NYSE:MMS)

Verus Financial Partners Inc. reduced its holdings in Maximus, Inc. (NYSE:MMSFree Report) by 31.8% in the 4th quarter, Holdings Channel reports. The fund owned 3,442 shares of the health services provider’s stock after selling 1,607 shares during the period. Verus Financial Partners Inc.’s holdings in Maximus were worth $264,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of MMS. Creative Planning boosted its stake in shares of Maximus by 17.7% during the 2nd quarter. Creative Planning now owns 15,205 shares of the health services provider’s stock valued at $1,303,000 after buying an additional 2,292 shares during the period. Sanctuary Advisors LLC purchased a new position in Maximus in the second quarter valued at about $216,000. Healthcare of Ontario Pension Plan Trust Fund increased its position in Maximus by 942.9% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider’s stock worth $27,707,000 after purchasing an additional 292,300 shares during the last quarter. Handelsbanken Fonder AB lifted its holdings in shares of Maximus by 18.4% during the 3rd quarter. Handelsbanken Fonder AB now owns 13,516 shares of the health services provider’s stock valued at $1,259,000 after buying an additional 2,100 shares during the last quarter. Finally, GAMMA Investing LLC grew its stake in shares of Maximus by 150.6% in the 3rd quarter. GAMMA Investing LLC now owns 862 shares of the health services provider’s stock valued at $80,000 after buying an additional 518 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Maximus

In related news, insider Michelle F. Link sold 2,208 shares of Maximus stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the sale, the insider now directly owns 6,567 shares of the company’s stock, valued at $484,841.61. This trade represents a 25.16 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Bruce Caswell purchased 3,500 shares of the stock in a transaction that occurred on Tuesday, December 17th. The shares were purchased at an average price of $70.64 per share, for a total transaction of $247,240.00. Following the completion of the purchase, the chief executive officer now directly owns 275,929 shares of the company’s stock, valued at approximately $19,491,624.56. This trade represents a 1.28 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 7,063 shares of company stock worth $502,017. Insiders own 1.60% of the company’s stock.

Maximus Trading Down 0.9 %

NYSE:MMS opened at $75.31 on Friday. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.59. The company’s 50 day moving average is $74.71 and its 200-day moving average is $83.99. The firm has a market cap of $4.30 billion, a price-to-earnings ratio of 15.06 and a beta of 0.73. Maximus, Inc. has a 12 month low of $69.72 and a 12 month high of $93.97.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Saturday, February 15th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.59%. Maximus’s dividend payout ratio (DPR) is presently 24.00%.

Wall Street Analysts Forecast Growth

MMS has been the subject of a number of analyst reports. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price for the company in a research note on Thursday, January 2nd. StockNews.com upgraded Maximus from a “hold” rating to a “buy” rating in a report on Wednesday.

Check Out Our Latest Stock Report on MMS

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Stories

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.